Patents by Inventor Arne Roseth

Arne Roseth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273166
    Abstract: It is described an instrument feeder device (201) for use in an endoscope system, for feeding a medical instrument (202) into a body or withdrawing the medical instrument from the body, the instrument feeding device comprising: a connector (302) for connecting the instrument feeding device (201) to a motor 5 (203) for moving the medical instrument (202) through the instrument feeding device (201); a drive wheel (303) arranged to be rotated by the motor, wherein the drive wheel (303) is positioned on one side of the medical instrument (202), an idler wheel (310) positioned on an opposite side of the medical instrument 10 relative the drive wheel (303), a clutch mechanism adapted to push the idler wheel (310) against the medical instrument (202), the clutch mechanism including a rotary button (1012) connected to a spindle (1111), the spindle including a main part (1111b) and an eccentric part (1111a) which is arranged offset relative a centre line through the main part, 15 wherein the idler wheel is rotatable m
    Type: Application
    Filed: September 10, 2019
    Publication date: September 1, 2022
    Inventors: Dag NORD, Stephan Andreas BRACKMANN, Lars Petter WALDØ-JENSEN, Arne RØSETH, Preben Rene HJALLUM, Erik Pavels PETERSEN
  • Publication number: 20220120747
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet. In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet, especially to determine the likelihood that the dietary intervention may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: December 27, 2021
    Publication date: April 21, 2022
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Patent number: 11243203
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: February 8, 2022
    Assignee: GENETIC ANALYSIS AS
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Publication number: 20200400666
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: August 31, 2020
    Publication date: December 24, 2020
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Patent number: 10794909
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: October 6, 2020
    Assignee: GENERIC ANALYSIS AS
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Publication number: 20200049708
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: October 13, 2017
    Publication date: February 13, 2020
    Inventors: Finn Terje HEGGE, Christina CASEN, Jorgen VALEUR, Arne ROSETH, Milada Cvancarova SMASTUEN
  • Publication number: 20180010989
    Abstract: A tube for mixing, diluting and preserving a sample includes a hollow first container for receiving and storing a solution, the first container having first and second ends, wherein at least the first end has a through-hole, and a transport-pin located in the through-hole of the first end having a shape closely matching to the through-hole, the transport-pin including a recess with a predetermined size. The recess is suitable to be filled by a sample, wherein the transport-pin is movable between an initial position in which the recess is positioned at least partially on the outer side of the first container, and an end position in which the recess is positioned at least partially on the inner side of the first container.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 11, 2018
    Applicant: BÜHLMANN LABORATORIES AG
    Inventors: Erik Pavels Petersen, Arne Roseth, Thomas Jermann, Jakob Weber
  • Patent number: 9752967
    Abstract: A tube for extracting, diluting and discharging a sample: able to control the amount of discharged diluted solution in the tube, after the sample has been diluted; that improves the hygienic conditions of discharging the sample; that enables introduction of a predetermined amount of a sample in any liquid or solid state; and that is able to transfer a specific amount of a diluted sample into another tube for further processing without any hygienic problems and with no risk of accidents.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: September 5, 2017
    Assignee: BÜHLMANN LABORATORIES AG
    Inventors: Erik Pavels Petersen, Arne Roseth, Thomas Jermann, Jakob Weber
  • Publication number: 20140352455
    Abstract: A tube for extracting, diluting and discharging a sample: able to control the amount of discharged diluted solution in the tube, after the sample has been diluted; that improves the hygienic conditions of discharging the sample; that enables introduction of a predetermined amount of a sample in any liquid or solid state; and that is able to transfer a specific amount of a diluted sample into another tube for further processing without any hygienic problems and with no risk of accidents.
    Type: Application
    Filed: January 18, 2013
    Publication date: December 4, 2014
    Inventors: Erik Pavels Peterson, Arne Roseth, Thomas Jermann, Jakob Weber